Bronchiectasis is a chronic respiratory condition characterized by the abnormal widening and scarring of the bronchial tubes, leading to recurrent infections and impaired lung function. The prevalence of bronchiectasis varies across different populations and geographical regions.
While precise global prevalence data is limited, studies suggest that bronchiectasis is more common than previously thought. In the United States, it is estimated that approximately 110,000 to 300,000 individuals are affected by bronchiectasis. In Europe, prevalence rates range from 52 to 566 cases per 100,000 people, with higher rates reported in countries with aging populations.
Furthermore, bronchiectasis is often associated with other underlying conditions such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and immunodeficiency disorders. The prevalence of bronchiectasis in individuals with cystic fibrosis is particularly high, affecting around 30% to 50% of patients.
Early diagnosis and appropriate management are crucial in improving outcomes for individuals with bronchiectasis. If you suspect you or someone you know may have bronchiectasis, it is important to consult a healthcare professional for proper evaluation and treatment.